| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2010 | From NPC therapeutic target identification to potential treatment strategy | Lan, Ming-Ying; Chen, Chi-Long; Lin, Kuan-Ting; Lee, Sheng-An; Yang, Wu-Lung R.; Hsu, Chun-Nan; Wu, Jaw-Ching; Ho, Ching-Yin; Lin, Jin-Ching; Huang, Chi-Ying F. | Molecular Cancer Therapeutics 9, 2511-2523 | | | |
| 2024 | PPAR-γ Agonists Reactivate the ALDOC-NR2F1 Axis to Enhance Sensitivity to Temozolomide and Suppress Glioblastoma Progression | Chang, Yu-Chan; Chan, Ming-Hsien; Li, Chien-Hsiu; Chen, Chi-Long; Tsai, Wen-Chiuan; Hsiao, Michael | CELL COMMUNICATION AND SIGNALING 22, 266 | | | |
| 2024 | RAB31 Drives Extracellular Vesicle Fusion and Cancer-associated Fibroblast Formation Leading to Oxaliplatin Resistance in Colorectal Cancer | Chang, Yu-Chan; Yang, Yi-Fang; Li, Chien-Hsiu; Chan, Ming-Hsien; Lu, Meng-Lun; Chen, Ming-Huang; Chen, Chi-Long; Hsiao, Michael | JOURNAL OF EXTRACELLULAR BIOLOGY 3(2), e141 | | | |
